Abstract
Immune intervention began almost two centuries ago when Jenner introduced vaccination with cowpox as a means of protecting against smallpox. This form of immune intervention plays a dominant role in the prevention of human disease. Furthermore, immunological approaches including radioimmunoassays, enzyme-linked immunoassays, microfluorometry, and modern molecular immunogenetics are critical in clinical diagnosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
G. Köhler and C. Milstein, Continuous cultures of fused cells secreting antibody of pre-defined specificity, Nature 256:495 (1975).
R. Catane and D.L. Longo, Monoclonal antibodies for cancer therapy, Isr. J. Med. Sci. 24:471 (1989).
T.A. Waldmann, Multichain interleukin-2 receptor: a target for immunotherapy in lymphoma, J. Natl. Cancer Inst. 81:914 (1989).
T.A. Waldmann, The interleukin-2 receptor, J. Biol. Chem. 266:2681 (1991).
P.T. Jones, P.H. Dear, J. Foote, M.S. Neuberger, and G. Winter, Replacing the complementarity-determining regions in a human antibody with those from a mouse, Nature 321:522 (1986).
C. Queen, W.P. Schneider, H.E. Selick, P.W. Payne, N.F. Landolfi, J.F. Duncan, N.M. Avdalovic, M. Levitt, R.P. Junghans, and T.A. Waldmann, A humanized antibody that binds to the IL-2 receptor, Proc. Natl. Acad. Sci. USA 86:10029 (1989).
R.P. Junghans, T.A. Waldmann, N.D. Landolfi, N.M. Avdalovic, W.P. Schneider, and C. Queen, Anti-Tac-H, a humanized antibody that binds the interleukin-2 receptor: a novel agent for immunotherapy in malignant and immune disorders, Cancer Res. 50:1495 (1990).
H. Lorberboum-Galski, R. Kozak, T. Waldmann, P. Bailon, D. FitzGerald, and I. Pastan, IL2-PE40 is cytotoxic to cells displaying either the p55 or p75 subunit of the IL-2 receptor, J. Biol. Chem. 263:18650 (1988).
V.K. Chaudhary, C. Queen, R.P. Junghans, T.A. Waldmann, D.J. FitzGerald, and I. Pastan, A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin, Nature 339:394 (1989).
R.W. Kozak, R.W. Atcher, O.A. Gansow, A.M. Friedman, J.J. Hines, and T.A. Waldmann, Bismuth-212 labeled anti-Tac monoclonal antibody: alpha-particle emitting radionuclides as modalities for radioimmunotherapy, Proc. Natl. Acad. Sci. USA 83:474 (1986).
R.W. Kozak, A. Raubitschek, S. Mirzadeh, M.W. Brechbiel, R. Junghans, O.A. Gansow, and T.A. Waldmann, Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: a critical factor in determining in vivo survival and organ toxicity, Cancer Res. 49:2639 (1989).
K.A. Smith, T-cell growth factor, Immunol. Rev. 51:337 (1980).
T.A. Waldmann, The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes, Science 232:727 (1986).
W.A. Kuziel and W.C. Greene, Interleukin-2 and the IL-2 receptor: new insights into structure and function, J. Invest. Dermatol. 94:27S (1990).
R.J. Robb, A. Munck, and K.A. Smith, T cell growth factor receptors. Quantification, specificity, and biological relevance, J. Exp. Med. 154:1455 (1981).
T. Uchiyama, S. Broder, and T.A. Waldmann, A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells, J. Immunol. 126:1393 (1981).
T. Uchiyama, D.L. Nelson, T.A. Fleischer, and T.A. Waldmann, A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells, Expression of Tac antigen on activated cytotoxic killer T-cells, suppressor cells, and one of two types of helper T cells, J. Immunol. 126:1398 (1981).
M. Tsudo, R.W. Kozak, C.K. Goldman, and T.A. Waldmann, Demonstration of a non-Tac peptide that binds interleukin-2: a potential participant in a multichain interleukin 2 receptor complex, Proc. Natl. Acad. Sci. USA 83:9694 (1986).
M. Tsudo, R.W. Kozak, C.K. Goldman, and T.A. Waldmann, Contribution of a p75 interleukin-2 binding peptide to a high-affinity interleukin-2 receptor complex, Proc. Natl. Acad. Sci. USA 84:4215 (1987).
M. Sharon, R.D. Klausner, B.R. Cullen, R. Chizzonite, and W.J. Leonard, Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions, Science 234:859 (1986).
M. Hatakeyama, M. Tsudo, S. Minamoto, T. Kono, T. Doi, T. Miyata, and T. Tomiguchi, Interleukin-2 receptor β chain gene: generation of three receptor fonns by cloned human ∝ and β chain cDNA’s, Science 244:551 (1989).
J.F. Bazan, Structural design and molecular evolution of a cytokine receptor superfamily, Proc. Natl. Acad. Sci. USA 87:6934 (1990).
J. Szöllösi, S. Damjanovich, C.K. Goldman, M.J. Fulwyler, A.A. Aszalos, G. Goldstein, P. Rao, M.A. Talle, and T.A. Waldmann, Flow cytometric resonance energy transfer measurements support the association of a 95-kDa peptide tenned T27 with the 55-kDa Tac peptide, Proc. Natl. Acad. Sci. USA 84:7246 (1987).
M. Sharon, J.R. Gnarra, M. Bamiyash, and W.J. Leonard, Possible association between IL-2 receptors and class I HLA molecules on T cells, J. Immunol. 141:3512 (1988).
J. Burton, C.K. Goldmann, P. Rao, M. Moos, and T.A. Waldmann, The association of intercellular adhesion molecule 1 with the multichain high-affinity interleukin-2 receptor, Proc. Natl. Acad. Sci. USA 87:7329 (1990).
M. Edidin, A. Aszalos, S. Damjanovich, and T.A. Waldmann, Lateral diffusion measurements give evidence for association of the Tac peptide of the IL-2 receptor with the T27 peptide in the plasma membrane of HUT-102-B2 T cells, J. Immunol. 141:1206 (1988).
L.A. Rubin, C.C. Kurman, W.E. Biddison, N.D. Goldman, and D.L. Nelson, A monoclonal antibody 7G7/B6 binds to an epitope on the human interleukin-2 (IL-2) receptor that is distinct from that recognized by IL-2 or anti-Tac, Hybridoma 4:91 (1985).
T.A. Waldmann, W.C. Greene, P.S. Sarin, C. Saxinger, D.W. Blayney, W.A. Blattner, C.K. Goldman, K. Bongiovanni, S. Sharrow, J.M. Depper, W. Leonard, T. Uchiyama, and R.C. Gallo, Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T-cell leukemia with human T-cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac: monoclonal antibody identifying the human receptor for T cell growth factor, J. Clin. Invest. 73:1711 (1984).
T. Uchiyama, T. Hori, M. Tsudo, Y. Wano, H. Umadome, S. Tamori, J. Yodoi, M. Maeda, H. Sawami, and H. Uchino, Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells, J. Clin. Invest. 76:446 (1985).
R. Schwarting, J. Gerdes, and H. Stein, Expression of interleukin-2 receptor on Hodgkin’s and non-Hodgkin’s lymphoma and macrophages, J. Clin. Pathol. 38:1196 (1985).
S.J. Korsmeyer, W.C. Greene, J. Cossman, S.M. Hsu, J.P. Jensen, L.M. Neckers, S.L. Marshall, A. Bakhshi, J.M. Depper, W.J. Leonard, E.S. Jaffe, and T.A. Waldmann, Rearrangement and expression of immunoglobulin genes and expression of Tac antigen in hairy cell leukemia, Proc. Natl. Acad. Sci. USA 80:4522 (1983).
T. Diamantstein and H. Osawa, The interleukin-2 receptor, its physiology and a new approach to a selective immunosuppressive therapy by anti-interleukin-2 receptor monoclonal antibodies, Immunol. Rev. 92:5 (1986).
T. Uchiyama, J. Yodoi, K. Sagawa, K. Takatsuki, and H. Uchino, Adult T-cell leukemia: clinical and hematologic features of 16 cases, Blood 50:481 (1977)
B.J. Poiesz, F.W. Ruscetti, A.F. Gazdar, P.A. Bunn, J.D. Minna, and R.C. Gallo, Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma, Proc. Natl. Acad. Sci. USA 77:7415 (1980).
M. Seiki, S. Hattori, Y. Hirayama, and M. Yoshida, Human adult T-ce1lleukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA, Proc. Natl. Acad. Sci. USA 80:3618 (1983).
J.G. Sodroski, C.A. Rosen, and W.A. Haseltine, Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells, Science 225:381 (1984).
T.A. Waldmann, C.K. Goldman, K.F. Bongiovanni, S.O. Sharrow, M.P. Davey, K.B. Cease, S.J. Greenberg, and D. Longo, Therapy of patients with human T cell lymphotrophic virus I-induced adult T-cell leukemia with anti-Tac, a monoclonal antibody to the receptor for interleukin-2, Blood 72:1805 (1988).
T.A. Waldmann, Monoclonal antibodies in diagnosis and therapy, Science 252:1659 (1991).
M. Maeda, N. Arima, Y. Daitoku, M. Kashihara, H. Okamoto, T. Uchiyama, K. Shirono, M. Matsuka, T. Hattori, K. Takatsuki, K. Ikuta, A. Shimuzu, T. Honjo, and J. Yodoi, Evidence for the interleukin-2 dependent expansion of leukemic cells in adult T-cell leukemia, Blood 70:1407 (1987).
J.M. Depper, W.J. Leonard, T.A. Waldmann, and W.C. Greene, Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation, J. Immunol. 131:690 (1983).
R.L. Kirkman, L.V. Barrett, and G.N. Gaulton, Administration of an anti interleukin-2 receptor monoclonal antibody prolongs cardiac allograft survival in mice, J. Exp. Med. 162:358 (1985).
M.H. Reed, M.E. Shapiro, T.B. Strom, E.L. Milford, C.B. Carpenter, D.S. Weinberg, K.A. Reimann, N.L. Letvin, T.A. Waldmann, and R.L. Kirkman, Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody, Transplantation 47:55 (1989).
P.S. Brown, Jr., G.L. Parenteau, F.M. Dirbas, R.J. Garsia, C.K. Goldman, M.A. Bukowski, R.P. Junghans, C. Queen, J. Hakimi, W. Benjamin, R.E. Clark, and T.A. Waldmann, Anti-Tac-H, a humanized antibody to the interleukin-2 receptor prolongs primate cardiac allograft survival, Proc. Natl. Acad. Sci. USA 88:2663 (1991).
R.L. Kirkman, M.E. Shapiro, C.B. Carpenter, D.B. McKay, D.L. Milford, E.L. Ramos, N.L. Tilney, T.A. Waldmann, C.E. Zimmerman, and T.B. Strom, A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation, Transplantation 51:107 (1991).
J. Hwang, D.J. FitzGerald, P. Adhya, and I. Pastan, Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli, Cell 48:129 (1987).
R.I. Kreitman, V.K. Chaudhary, T.A. Waldmann, M.C. Willingham, D.I. FitzGerald, and I. Pastan, The recombinant immunotoxin anti-Tac (Fv)-PE40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia, Proc. Natl. Acad. Sci. USA 87:8291 (1990).
M.M. Cooper, R.C. Robbins, C.K. Goldman, S. Mirzadeh, C. Stone, O.A. Gansow, R.E. Clark, and T.A. Waldmann, Use of yttrium-90-labeled anti-Tac antibody in primate xenograft transplantation, Transplantation 50:760 (1990).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Waldmann, T.A. et al. (1992). The Interleukin-2 Receptor: A Target for Immunotherapy. In: Gupta, S., Waldmann, T.A. (eds) Mechanisms of Lymphocyte Activation and Immune Regulation IV. Advances in Experimental Medicine and Biology, vol 323. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3396-2_8
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3396-2_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6500-6
Online ISBN: 978-1-4615-3396-2
eBook Packages: Springer Book Archive